Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 47 for “"avibactam"”.
-
Μηχανισμοί αντοχής στον αναστολέα καρβαπενεμασών avibactam
H Avibactam είναι ένας νέος αναστολέας β-λακταμάσης που χρησιμοποιείται συχνά σε συνδυασμό με την Ceftazidime για τη θεραπεία λοιμώξεων που προκαλούνται από πολυανθεκτικά βακτήρια. Παρά το γεγονός ότι ο συγκεκριμένος αναστολέας είναι αποτελεσματικός έναντι πολλών βακτηριακών στελεχών, ορισμένα …
-
Avaliação do sinergismo entre ceftazidima/avibactam-aztreonam e aztreonam/avibactam frente a Klebsiella pneumoniae utilizando espectrometria de massa maldi-tof
… avaliar o sinergismo das combinações ceftazidima/avibactam associada ao aztreonam e aztreonam/avibactam frente a isolados clínicos produtores de NDM, utilizando a espectrometria de massas MALDI-TOF como ferramenta fenotípica rápida para análise do crescimento bacteriano. Foram incluídos no estudo …
-
Synthetic Data–Driven Early Prediction Framework for Acute Kidney Injury in Patients Receiving Vancomycin and Ceftazidime/Avibactam
… The nephrotoxic risks of combining ceftazidime/avibactam (AVI) with vancomycin (VAN) remain underexplored, despite both agents independently being linked to acute kidney injury (AKI). This study assessed the risk of AKI associated with concurrent VAN and ceftazidime/avibactam (VAN-AVI) therapy …
-
Avaliação de desfechos clínicos e microbiológicos em pacientes em uso de ceftazidima-avibactam : um estudo de coorte multicêntrico prospectivo
… de novas drogas para tratamento. O ceftazidima-avibactam é a combinação de uma cefalosporina de 3ª geração com um novo inibidor de beta-lactamase. Esta combinação foi criada com objetivo específico de tratar bactérias produtoras de KPC e OXA-48. Apesar de melhores resultados quando comparado às …
-
Adding insult to injury: mechanistic basis for how AmpC mutations allow Pseudomonas aeruginosa to accelerate cephalosporin hydrolysis and evade avibactam
… ceftolozane/tazobactam and ceftazidime/avibactam. The objective of this thesis was to investigate the enzymatic activity of four of these reported AmpC mutants, E247K, G183D, T96I, and ∆G229–E247 (alongside wild-type (WT) AmpC from P. aeruginosa PAO1), to gain detailed insights into how …
-
Understanding Staphylococcus aureus β-lactam resistance : a structural investigation
… when acylated by a β-lactam antibiotic. Here, avibactam, a diazabicyclooctane β- lactamase inhibitor, was found to induce expression of pbp2a (which codes for PBP2a) and blaZ (which codes for PC1) in a clinical strain of MRSA. The X-ray crystallographic structures of the iv BlaR1 and MecR1 …
-
Systems Pharmacology Approaches to Describe and Exploit the Pathways to Polymyxin and β-lactam Resistance in Metallo-β-lactamase-producing Gram Negatives
… use of aztreonam in combination with ceftazidime/avibactam would revitalize aztreonam activity through inhibition of ESBLs by avibactam. In order to provide guidance on the utilization of this combination, this dissertation focused on converting literature-based population pharmacokinetic studies …
-
Protecting our beta-lactam antibiotic assets : structural investigation of beta-lactamases
… The novel diazabicyclooctane (DBO) avibactam inhibits a wider range of serine β-lactamases than has been previously observed with clinical β-lactamase inhibitors. To understand the molecular basis and spectrum of inhibition by avibactam, we provide structural and mechanistic analysis …
-
The efficacy of aspergillomarasmine A to overcome β-lactam antibiotic resistance
… combination was evaluated with and without avibactam, a potent SBL inhibitor. This study used ten Escherichia coli and ten Klebsiella pneumoniae laboratory strains as well as 30 clinical strains producing at least one MBL and one SBL. Once establishing that the AMA/avibactam/meropenem …
-
Insights into antibiotic inactivation by β-lactamases from multiscale simulations
… of the non-β-lactam β-lactamase inhibitor avibactam against OXA-48 are compared to deduct the most plausible acylation pathway. The QM/MM potential energy profiles show that avibactam most likely utilises a similar mechanism to β-lactam substrates, where a carboxylated Lys73 acts as a …
-
Avaliação de metodologias alternativas para a detecção rápida e acurada de resistência às opções terapêuticas no tratamento de bacilos gram-negativos resistentes aos carbapenêmicos
… mortalidade. A combinação aztreonam/ceftazidima-avibactam e as polimixinas são opções terapêuticas essenciais para o tratamento de infecções por BGN-RC, especialmente em casos de isolados produtores de metalo-beta-lactamases, associadas ou não a serina-carbapenemases. A administração precoce e …
-
Investigation on the molecular mechanism of 2OG-oxygenases and serine β-lactamases through computational chemistry
… to investigate recyclisation and hydrolysis in avibactam mediated serine β-lactamase inhibition. β-Lactams inhibit penicillin-binding proteins (PBPs) and serine β-lactamases by acylation of a nucleophilic active site serine. Avibactam is approved for clinical use in combination with a …
-
Mecanismos de resistencia y virulencia de aislados clínicos de klebsiella spp. Productores de beta-lactamasas de clase a, c y d: caracterización de los cambios producidos durante la colonización/infección
… a la aparición de resistencia a ceftazidima/avibactam y la dinámica de plásmidos en aislados del género Klebsiella. Este estudio busca proporcionar información clave para anticiparnos a la evolución de estos microorganismos y desarrollar estrategias terapéuticas más eficaces en su manejo …
-
Mechanism Elucidation and Inhibitor Discovery against Serine and Metallo-Beta-Lactamases Involved in Bacterial Antibiotic Resistance
… against the class A KPC and MBLs, NDM and VIM. Avibactam and vaborbactam are novel BLIs approved in the last two years that have activity against serine carbapenemases (e.g., KPC), but do not inhibit MBLs. The overall goals of this project were to use X-ray crystallography to study the catalytic …
-
Using NMR to study protein-ligand interactions
… in β-lactam hydrolysis. The susceptibility of avibactam, the first clinically useful non-β-lactam βlactamase inhibitor, to MBL-catalysed hydrolysis was studied. The results reveal that avibactam is not an MBL inhibitor and a poor substrate of most members of all three clinically relevant …
-
Desenvolvimento de metodologias rápidas para detecção de mecanismos de resistência bacteriana e determinação da suscetibilidade a antimicrobianos em Enterobacterales por MALDI-TOF MS
… meropenem a partir de colônia, para ceftazidima/avibactam e meropenem a partir de hemocultura e para a detecção de sinergismo da combinação de aztreonam e ceftazidima/avibactam.
-
Characterisation of β-lactam/Vaborbactam activity in Klebsiella pneumoniae
… meropenem/vaborbactam and ceftazidime/avibactam has revolutionised the management of cephalosporin and carbapenem resistant K. pneumoniae infections. With an increasing clinical dependence on these combination therapies, there is a need to study resistance mechanisms to allow prediction …
-
DISCOVERY AND CHARACTERIZATION OF NOVEL BETA-LACTAMASE INHIBITORS
… of the diazabicyclooctane (DBO) SBL inhibitor, avibactam. Herein, I describe efforts directed at understanding the mechanism of avibactam SBL inhibition. Furthermore, DBO derivatives are shown to display bifunctional properties in inhibiting both β-lactamases and the targets of β-lactam …
-
Understanding the structure and function of proteins involved in the inducible expression of AmpC β-lactamase
… in synergy with the potent β-lactamase inhibitor avibactam in an ampC derepressed P. aeruginosa strain. Finally, the potency of avibactam was also structurally defined in a recently discovered class A serine carbapenemase from Vibrio cholerae. Collectively, this research explores a number of small …
Page 1 of 3